ClearB Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing therapies aimed at achieving functional cure in patients with chronic hepatitis B (CHB) infection, announced that the sentinel subject safety review in their ongoing Phase 1b study of CLB-4000 supports…
PeptiDream Inc., PDRadiopharma Inc. — a wholly owned subsidiary of PeptiDream — and Curium Group, a global leader in nuclear medicine, have announced the initiation of a registrational Phase 2 clinical trial in Japan for 64Cu-PSMA-I&T, a novel PET radiopharmaceutical…
Eradivir Inc., a clinical-stage biotechnology company leveraging the immune system to treat infectious diseases, today announced the successful completion of its Phase 2a clinical trial evaluating EV25, a novel therapy for influenza. The trial demonstrated that EV25 is safe, well-tolerated,…
Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on integrating advanced engineering with cutting-edge laboratory and in silico research to accelerate drug discovery, today announced that new data from its ongoing Phase 2 study of EIK1001 (TeLuRide-005) will be…
Augurex Life Sciences Corp., a leading innovator in autoimmune-based diagnostics, today announced a strategic agreement with MitogenDx, a Canadian specialty laboratory focused on autoimmune and rheumatology diagnostic testing. Under the terms of the agreement, MitogenDx will offer the JOINTstat® blood…
ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer and Shionogi as shareholders, announced new data from the phase I CLARITY open-label crossover study, highlighting significant differences in injection site reaction (ISR) acceptability and overall tolerability between…
Echo, a global leader in hydrogen wellness technology, has highlighted new research that strengthens the case for molecular hydrogen (H₂) as a powerful aid in lung recovery and inflammation reduction following high-intensity exercise. The study, recently published in the Journal…
Oticara, a clinical-stage pharmaceutical company focused on developing innovative therapies for chronic rhinosinusitis (CRS), announced encouraging results from its Phase 2 OT-007B clinical trial. The study evaluated Oticara’s proprietary nasal-mucosa-optimized steroid cream in patients suffering from persistent CRS symptoms after…
Alzheon, Inc., a clinical-stage biopharmaceutical company advancing novel therapies and diagnostics for Alzheimer’s disease (AD) and other neurodegenerative disorders, announced the peer-reviewed publication of its pivotal APOLLOE4 Phase 3 trial results in Drugs, a leading scientific journal. The paper, titled…
The Estée Lauder Companies Inc., under the High Patronage of Mr. Emmanuel Macron, President of the French Republic, has officially opened its Fragrance Atelier within La Maison des Parfums on Rue Volney in Paris. This state-of-the-art facility represents a major…